COc1ccc2[nH]cc([C@@H]3C4CCC(C4)[C@H]3NCc3cccc(CN[C@H]4C5CCC(C5)[C@@H]4c4c[nH]c5ccc(OC)cc45)c3)c2c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?